CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39 enrolled
Drug / intervention
Pulmonary Artery Catheter (PAC) +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01877941
NCT01877941N/ACompleted

Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time

University of California, San Francisco·interventional·Posted Jun 14, 2013·Updated Jan 1, 2015

In Brief

A clinical study evaluating Pulmonary Artery Catheter (PAC), Endotracheal Cardiac Output Monitor (ECOM), and 1 other intervention for Myocardial Infarction and Myocardial Ischemia. Completed, enrolled 39 participants across 2 sites.

Detailed Summary

The specific aim of this study is to assess whether a device approved by the FDA to measure pulse oximetry can accurately estimate cardiac output.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 14, 2013
Enrollment StartDec 1, 2012
Primary CompletionNov 1, 2013
Study CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 13.0 years ago

Interventions

Pulmonary Artery Catheter (PAC)device

A catheter is inserted into the pulmonary artery, through the internal jugular vein; cardiac output is indicated by the speed that a temperature gradient dissipates.

Endotracheal Cardiac Output Monitor (ECOM)device

An FDA-approved medical device is inserted into the patient's throat; cardiac output is calculated by measuring how electricity moves through the chest.

Estimated Continuous Cardiac Output (esCCO)device

Sensors are placed on the arm, finger and leg to calculate Pulse Wave Transit Time (PWTT); the time it takes for the pulse of the heartbeat to travel through the body.